RENALYTIX PLC - AMERICAN DEPOSITARY SHARES

Renalytix to Present at the 41st Annual Canaccord Genuity Global Growth Conference

26 июл 2021 07:00:00 Источник Nasdaq GlobeNewswire

Renalytix Appoints Joseph Hutson Vice President of Global Quality and Regulatory

22 июл 2021 07:00:00 Источник Nasdaq GlobeNewswire

KidneyIntelX™ Enables Monitoring of SGLT2 Inhibitor Therapy Response and Corresponding Risk Reduction Over Time

28 июн 2021 07:00:00 Источник Nasdaq GlobeNewswire

Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2021

15 июн 2021 07:00:01 Источник Nasdaq GlobeNewswire

Renalytix to Report Financial Results for Fiscal Third Quarter 2021 and Provide Corporate Update

10 июн 2021 08:00:01 Источник Nasdaq GlobeNewswire

Leadership Additions Announced to Support Expanding US Government and Healthcare Provider KidneyIntelX Deployment

07 июн 2021 07:00:01 Источник Nasdaq GlobeNewswire

Utility Study Indicates KidneyIntelX Risk Assessment can Address Treatment Ambiguity in Primary Care

03 июн 2021 07:00:01 Источник Nasdaq GlobeNewswire

U.S. General Services Administration Grants 10-Year Governmentwide Contract for RenalytixAI KidneyIntelX Testing

22 апр 2021 07:00:01 Источник Nasdaq GlobeNewswire

KidneyIntelX Demonstrates Performance and Informs Treatment Decisions in Multinational CANagliflozin CardioVAScular Assessment Study (CANVAS)

20 апр 2021 07:00:00 Источник Nasdaq GlobeNewswire

RenalytixAI and Joslin Diabetes Center Build on Proprietary Kidney Biomarker Portfolio for KidneyIntelX Platform

14 апр 2021 07:00:01 Источник Nasdaq GlobeNewswire

Clinical Utility Study Demonstrates Primary Care Physicians Highly Likely to Order KidneyIntelX to Inform Care Decisions

08 апр 2021 07:00:00 Источник Nasdaq GlobeNewswire

Multi-Center Study Finds KidneyIntelX 72% More Effective Than Current Standard of Care In Identifying Early-Stage Patients at High Risk for Kidney Disease Progression and Failure

05 апр 2021 07:00:00 Источник Nasdaq GlobeNewswire

Update on Finalization of MCIT Rule to Provide National Medicare Coverage for FDA Breakthrough Devices and Diagnostics

15 мар 2021 07:00:01 Источник Nasdaq GlobeNewswire

Renalytix AI plc Issue of Shares Under the 2020 Employee Share Purchase Plan, PDMR Dealing and Total Voting Rights

04 мар 2021 13:00:00 Источник Nasdaq GlobeNewswire

RenalytixAI Reports Financial Results for Second Quarter of Fiscal Year 2021

02 мар 2021 07:00:03 Источник Nasdaq GlobeNewswire

The University of Utah and RenalytixAI Partner to Drive Innovation in Kidney Health

24 фев 2021 08:00:03 Источник Nasdaq GlobeNewswire

RenalytixAI to announce Financial Results for six and three months ended December 31, 2020

23 фев 2021 02:00:00 Источник Nasdaq GlobeNewswire

American Society of Nephrology and Renalytix to Co-Host Virtual Capital Markets Day for Kidney Health

04 фев 2021 07:00:01 Источник Nasdaq GlobeNewswire

Renalytix Commends HHS/CMS on Finalization of MCIT Rule to Provide National Medicare Coverage for FDA Breakthrough Devices and Diagnostics

13 янв 2021 02:00:00 Источник Nasdaq GlobeNewswire

Early Risk Identification at Core of Innovative Kidney Care Partnership Between Renalytix, DaVita

05 янв 2021 06:00:00 Источник Nasdaq GlobeNewswire